Sort
48,018 grants matching “immunotherapy”
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$402,394Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$402,394Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$402,394Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
The structural and functional basis of MET exon 14 activation and acquired drug resistance
$402,355Natalia Jura · University Of California, San Francisco · R01 · FY2022 · CA
SOUTHWEST ONCOLOGY GROUP--SUMMARY
$402,352Loyola University Chicago · U10 · FY2003 · CA
Pathogensis of Bacterial corneal infection
$402,326Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2010 · EY
A prognostic mRNA immune signature for resected stage II-III melanoma
$402,257Yvonne Margaret Saenger · Albert Einstein College Of Medicine · UH3 · FY2022 · CA
Evaluation of Immune-based Combinations in Metastatic Prostate Cancer
$402,223Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Engineering the Brain Immune System for Tumor Therapy
$402,188Maria G Castro · Cedars-Sinai Medical Center · R01 · FY2010 · NS
Stromal metabolism promotes therapeutic resistance in pancreatic cancer
$402,177Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$402,156Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2021 · CA
Controlled Release of Macromolecules
$402,150Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2010 · EB
Salmonella as a vector for delivery of oncolytic viruses to hepatocellular carcinoma
$402,147Neil S Forbes · University Of Massachusetts Amherst · R21 · FY2024 · CA
Cancer and Leukemia Group B - The Ohio State University
$402,122Ohio State University · U10 · FY2003 · CA
Arenavirus Receptor-Structure/Function Studies
$402,083Michael B Oldstone · Scripps Research Institute, The · R01 · FY2010 · AI
Early Stage Studies of a Novel Positive Allosteric Modulator of the Alpha1-Adrenergic Receptor to Treat Alzheimer's Disease
$402,083Dianne M Perez · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · AG
PROTEAN-CR: Proteomics Toolkit for Ensemble Analysis in Cancer Research
$402,077Lydia E. Kavraki · Rice University · U01 · FY2021 · CA
Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer
$402,035Pier P Scaglioni · University Of Cincinnati · R01 · FY2025 · CA
Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer
$402,035Pier P Scaglioni · University Of Cincinnati · R01 · FY2022 · CA
ANTIBODY-TARGETED IMMUNOTHERAPY OF CANCER
$402,025Fox Chase Cancer Center · R01 · FY2000 · CA
Advancing the Coordinating Center for the Canine Cancer Immunotherapy Network
$401,993Nicola J Mason · University Of Pennsylvania · U24 · FY2024 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$401,968Melanie R Rutkowski · University Of Virginia · R01 · FY2021 · CA
The use of chitosan for cancer vaccine delivery
$401,951John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Engineering Stem Cells for Islet Cell Replacement
$401,894Timothy James Kieffer · University Of British Columbia · R01 · FY2019 · DK
Self-renewing Lymphocyte Division in The Immune Response
$401,867Steven L Reiner · Columbia University Health Sciences · R56 · FY2021 · AI